Optimized basic conditions are essential for successful siRNA transfection into primary endothelial cells

Oligonucleotides

Volumn 19, Issue 2, 2009, Pages 141-149

  Nolte, Andrea ^a   Raabe, Claudia ^a   Walker, Tobias ^a   Simon, Perikles ^a   Ziemer, Gerhard ^a   Wendel, Hans Peter ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA1 INTERFERON; CATION; CYTOKINE; DOUBLE STRANDED RNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERFERIN; LIPOFECTAMINE; LIPOSOME; OAS1 PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; SMALL INTERFERING RNA; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; RNA INTERFERENCE; SERUM;

CELLS, CULTURED; E-SELECTIN; ENDOTHELIAL CELLS; HUMANS; INDICATORS AND REAGENTS; INTERFERONS; LIPIDS; LIPOSOMES; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 66249112520     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2009.0182     Document Type: Article

References (22)

1. AXEL, D.I., SPYRIDOPOULOS, I., RIESSEN, R., RUNGE, H., VIEBAHN, R., and KARSCH, K.R. (2000). Toxicity, uptake kinetics and efficacy of new transfection reagents: increase of oligonucleotide uptake. J. Vasc. Res. 37, 221-234.
2. BRIDGE, A.J., PEBERNARD, S., DUCRAUX, A., NICOULAZ, A.L., and IGGO, R. (2003). Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264.
3. COLLINS, T., WILLIAMS, A., JOHNSTON, G.I., KIM, J., EDDY, R., SHOWS, T., GIMBRONE, M.A., Jr., and BEVILACQUA, M.P. (1991). Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J. Biol. Chem. 266, 2466-2473.
4. CROOK, K., STEVENSON, B.J., DUBOUCHET, M., and PORTEOUS, D.J. (1998). Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum. Gene Ther. 5, 137-143.
5. DALBY, B., CATES, S., HARRIS, A., OHKI, E.C., TILKINS, M.L., PRICE, P.J., and CICCARONE, V.C. (2004). Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods 33, 95-103.
6. DORSETT, Y., and TUSCHL, T. (2004). siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3, 318-329.
7. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
8. FIRE, A., XU, S., MONTGOMERY, M.K., KOSTAS, S.A., DRIVER, S.E., and MELLO, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
9. GAO, X., and HUANG, L. (1995). Cationic liposome-mediated gene transfer. Gene Ther. 2, 710-722.
10. GITLIN, L., KARELSKY, S., and ANDINO, R. (2002). Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418, 430-434.
11. JACQUE, J.M., TRIQUES, K., and STEVENSON, M. (2002). Modulation of HIV-1 replication by RNA interference. Nature 418, 435-438.
12. MARQUES, J.T., and WILLIAMS, B.R. (2005). Activation of the mammalian immune system by siRNAs. Nat. Biotechnol. 23, 1399-1405.
13. MEISTER, G., and TUSCHL, T. (2004). Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343-349.
14. MOSS, E.G., and TAYLOR, J.M. (2003). Small-interfering RNAs in the radar of the interferon system. Nat. Cell Biol. 5, 771-772.
15. NCHINDA, G., UBERLA, K., and ZSCHORNIG, O. (2002). Characterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition. BMC Biotechnol. 2, 12.
16. ROZEN, S., and SKALETSKY, H. (2000). Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365-386.
17. SEMIZAROV, D., FROST, L., SARTHY, A., KROEGER, P., HALBERT, D.N., and FESIK, S.W. (2003). Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl. Acad. Sci. USA 100, 6347-6352.
18. SIMON, P., FELDKAEMPER, M., BITZER, M., OHNGEMACH, S., and SCHAEFFEL, F. (2004). Early transcriptional changes of retinal and choroidal TGFbeta-2, RALDH-2, and ZENK following imposed positive and negative defocus in chickens. Mol. Vis. 10, 588-597.
19. SLEDZ, C.A., HOLKO, M., DE VEER, M.J., SILVERMAN, R.H., and WILLIAMS, B.R. (2003). Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834-839.
20. STARK, G.R., KERR, I.M., WILLIAMS, B.R., SILVERMAN, R.H., and SCHREIBER, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
21. WALKER, T., WENDEL, H.P., TETZLOFF, L., HEIDENREICH, O., and ZIEMER, G. (2005). Suppression of ICAM-1 in human venous endothelial cells by small interfering RNAs. Eur. J. Cardiothorac. Surg. 28, 816-820.
22. YANG, J.P., and HUANG, L. (1998). Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene Ther. 5, 380-387.